SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-15-029700
Filing Date
2015-04-23
Accepted
2015-04-23 16:03:56
Documents
6
Period of Report
2015-06-10
Effectiveness Date
2015-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a15-8833_1def14a.htm DEF 14A 725948
2 GRAPHIC g88331cci001.gif GRAPHIC 2822
3 GRAPHIC g88331cci002.jpg GRAPHIC 2696
4 GRAPHIC g88331cci003.gif GRAPHIC 2494
5 GRAPHIC g88331dci001.gif GRAPHIC 130797
6 GRAPHIC g88331dci002.gif GRAPHIC 42697
  Complete submission text file 0001104659-15-029700.txt   977783
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-658-4749
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36562 | Film No.: 15788472
SIC: 2834 Pharmaceutical Preparations